Skip to main content
Clinical Trials/CTRI/2023/04/051346
CTRI/2023/04/051346
Recruiting
Phase 4

ASSESSING THE EFFECT OF INCREASING THE DOSE OF FOLIC ACID SUPPLEMEMENTATION IN PATIENTS OF RHEUMATOID ARTHRITIS WITH METHOTREXATE INTOLERANCE – A RANDOMISED CONTROLLED TRIA

PGIMER, Chandigarh0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified
Sponsor
PGIMER, Chandigarh
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Age between 18 and 75 years
  • 2\. Diagnosis of RA made as per ACR EULAR 2010 criteria
  • 3\. Currently receiving methotrexate for more than 3 months
  • 4\. Methotrexate Intolerance Severity Assessment Score \>4 qualifying as methotrexate intolerance

Exclusion Criteria

  • Unable to follow up at 16 weeks

Outcomes

Primary Outcomes

Not specified

Similar Trials